#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Trigeminal neuralgia Epstein-Barr virus associated lymphoproliferative disorder Astrocytoma Glomerulonephritis membranous Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Fontan procedure Thalassaemia alpha Adrenocortical carcinoma Hepatoblastoma Infective uveitis Mycobacterium abscessus infection Heavy menstrual bleeding Glomerulonephritis membranoproliferative Anti-HLA antibody test positive Germ cell cancer More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma – Treatment Extranodal marginal zone B-cell lymphoma (MALT type) – Trials in Disease Angiosarcoma – Life with Disease Langerhans cell sarcoma – Diagnostics Ehlers-Danlos syndrome – Treatment Medulloblastoma Mast cell activation syndrome – Diagnostics Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Basic Information Carcinoid syndrome Antisynthetase syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Diclofenac IG-TREGS Ceftolozane REGN7544 Haloperidol Hst-1011 Sodium Iodide (123 I) Cyclophosphamide Batoclimab Benralizumab Nms-03592088 Calcifediol Flortaucipir (18F) AZD1163 Alizapride Adenosine Adezunap Posdinemab ZODASIRAN Alxn2220 More therapies…

    Learn about Your Condition

    Dementia with Lewy bodies Synovitis Frontotemporal dementia Vertebrobasilar stroke Oesophageal food impaction Malignant mast cell neoplasm Oesophageal atresia Pericarditis Splenic marginal zone lymphoma Dizziness Urinary tract infection Peritoneal neoplasm Cervix carcinoma stage II Septic shock Optic ischaemic neuropathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Diagnostics And Consultation Center Convex Ltd.

Diagnostics And Consultation Center Convex Ltd.

Ulitsa Sinanishko Ezero 11a, Sofia, 1680, Bulgaria

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Obexelimab Treatment for Adults with Systemic Lupus Erythematosus (SLE)

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Obexelimab
    • Betamethasone Sodium Phosphate
    Belgium Bulgaria Denmark Germany Greece Italy +4

  • Study on the Long-Term Safety of STAR-0215 for Adults with Hereditary Angioedema

    Not recruiting

    2 1 1
    Investigated Drugs:
    • NAVENIBART
    Bulgaria Czechia Germany Poland

  • Study on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Barzolvolimab
    • Epinephrine
    Bulgaria Croatia Germany Hungary Italy Lithuania +4

  • Study on JTT-861 for Patients with Heart Failure with Reduced Ejection Fraction

    Not recruiting

    2 1
    Investigated Drugs:
    • Jtt-861 Monohydrochloride Dihydrate
    Bulgaria Czechia Poland Romania Spain

  • Study on Baxdrostat for Reducing Blood Pressure in Patients with Uncontrolled or Resistant Hypertension

    Not recruiting

    3 1
    Investigated Diseases:
    • Hypertension
    Investigated Drugs:
    • Baxdrostat
    Austria Belgium Bulgaria Czechia Denmark France +8

  • Study on Oral PHA-022121 for Preventing Angioedema Attacks in Patients with Hereditary Angioedema

    Not recruiting

    2 1
    Investigated Diseases:
    • Hereditary angioedema
    • Hereditary angioedema with C1 esterase inhibitor deficiency
    Investigated Drugs:
    • (S)-N-(1-Deutero-1-(3-Chloro-5-Fluoro-2-((2-Methyl-4-(1-Methyl-1H-1,2,4-Triazol-5-Yl)Quinolin-8-Yloxy)Methyl)Phenyl)Ethyl)-2-(Difluoromethoxy)Acetamide
    Austria Bulgaria Germany Ireland Italy Poland

  • Study on the Effectiveness and Safety of Fluticasone Propionate and Salbutamol Sulfate for Patients with Asthma

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Salbutamol Sulfate
    • Fluticasone Propionate
    Bulgaria Czechia Denmark Germany Greece Hungary +6

  • Study on the Effectiveness and Safety of Rosnilimab for Patients with Moderate to Severe Ulcerative Colitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Rosnilimab
    Austria Bulgaria Croatia France Germany Italy +4

  • Study on Baxdrostat for Lowering Blood Pressure in Patients with Resistant Hypertension

    Not recruiting

    3 1
    Investigated Drugs:
    • Baxdrostat
    Belgium Bulgaria Czechia Germany Greece Hungary +3

  • Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Evolocumab
    Austria Belgium Bulgaria Czechia Denmark Estonia +16
Previous Page
1 … 5 6 7 8 9 10
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!